Accolade Other Stockholder Equity from 2010 to 2025

ACCD Stock  USD 3.44  0.02  0.58%   
Accolade's Other Stockholder Equity is increasing over the years with slightly volatile fluctuation. Overall, Other Stockholder Equity is expected to go to about 1.8 B this year. During the period from 2010 to 2025 Accolade Other Stockholder Equity annual values regression line had coefficient of variation of  131.20 and r-squared of  0.71. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2019-02-28
Previous Quarter
1.5 B
Current Value
1.5 B
Quarterly Volatility
531.8 M
 
Covid
Check Accolade financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accolade's main balance sheet or income statement drivers, such as Tax Provision of 1.2 M, Net Interest Income of 7.2 M or Interest Income of 218 K, as well as many indicators such as Price To Sales Ratio of 1.89, Dividend Yield of 0.0 or PTB Ratio of 0.79. Accolade financial statements analysis is a perfect complement when working with Accolade Valuation or Volatility modules.
  
Check out the analysis of Accolade Correlation against competitors.
For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.

Latest Accolade's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Accolade over the last few years. It is Accolade's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accolade's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Accolade Other Stockholder Equity Regression Statistics

Arithmetic Mean548,455,567
Coefficient Of Variation131.20
Mean Deviation633,892,904
Median64,874,000
Standard Deviation719,597,245
Sample Variance517820.2T
Range1.9B
R-Value0.84
Mean Square Error162794.7T
R-Squared0.71
Significance0.000046
Slope127,049,975
Total Sum of Squares7767302.9T

Accolade Other Stockholder Equity History

20251.8 B
20241.7 B
20231.5 B
20221.4 B
20211.4 B
2019286.9 M
2018-130.8 M

About Accolade Financial Statements

Accolade stakeholders use historical fundamental indicators, such as Accolade's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Accolade investors may analyze each financial statement separately, they are all interrelated. For example, changes in Accolade's assets and liabilities are reflected in the revenues and expenses on Accolade's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Accolade. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity1.7 B1.8 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports:
Check out the analysis of Accolade Correlation against competitors.
For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.02)
Revenue Per Share
5.706
Quarterly Revenue Growth
0.098
Return On Assets
(0.07)
Return On Equity
(0.19)
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.